RNA viruses have a high spontaneous mutation rate, which rarely leads to a viable virus. But when they do, the new virus might be transmissible to humans and not be recognized by our immune system. This is how the new coronavirus Covid-19 emerged, causing worldwide fear. Yet, many virologists, biologists, and medics are remaining calm and investigating a vaccine and treatment. As materials researchers, what could we do?
Schematics of the general structure of coronaviruses featuring spike proteins in the outer layer (credit: Nature Publishing group).
Materials science is multidisciplinary, and applies to many fields. Materials can be bio, electronic, dense, porous, passive, active, etc. As a consequence, materials science can play a role in many aspects in the fight against Covid-19, such as in the following areas:
- identification. To be able to elaborate an adequate response to the effects of the virus, it is necessary to know more about it, and in particular its structure. For example, knowing how the proteins forming the virus are folded and assembled in 3 dimensions can help to identify sites where a medical treatment could interact and stop the replication of the virus. Current microscopy methods such as cryogenic electron microscopy (cryo-EM)—where a nanoparticle, a protein assembly, or a virus is frozen and observed under many angles—has already been used to reconstruct with nanometric resolution the complex structure of coronaviruses. The folding of the spike proteins in the outer shell of a feline coronavirus was thus imaged.
3D electron density map recorded by cryo-EM of a spike protein of a coronavirus at 0.33 nm resolution and revealing a trimer structure with 18 nm diameter and 17 nm height (credit: PNAS).
- treatment. The acute symptoms of the coronavirus infection are similar to pneumonia, which is treated by injection of pain relievers and anti-inflammatory drugs. Encapsulating the treatment inside a protective and functional micrometric shell can help deliver the medicine to the infected area more effectively. For example, small microparticles loaded with the drugs were developed to be directly inhaled by the patient. Thanks to the small size of the microparticles, below 10 µm, it is possible to deliver high loads of drugs while reaching the small and deep capillaries in the lungs.
- diagnosis. Regular temperature checks have been implemented to identify infected patients, but other methods may be able to detect the presence of the virus before the appearance of the symptoms. In particular, lab-on-a-chip devices could be used to determine the early presence of the virus. Such chips are only 3 cm long and sequence the genome from infected cells using microfluidics and DNA-assays. It was developed earlier for other coronaviruses. Could such devices be implemented on our smartphones, like demonstrated earlier this year for early detection of malaria?
- prevention of spreading. Wearing a facemask or an N95 respirator is one way to avoid the propagation of droplets containing the virus from a person who carries it to another who is healthy. However, wearing masks is protective for only a couple of hours. Longer than this, the humidity from the breath widens the pores and opens the barrier. Besides, the filtrating capability of such masks is usually limited to particles above 300 nm diameter, whereas the coronavirus may range around 50 to 200 nm diameter only. However, new materials and fabrication technologies might be promising alternatives, such as a recently developed electrospun textile based on silk and graphene. Due to the ultra-high aspect ratio of graphene, a mat with a pore size below 10 nm is created, blocking nano-pollutants including viruses while maintaining the passage of air.